European exchange on the practice and current issues in opioid substitution treatment in General Practitioners' settings

The EMCDDA, in partnership with the French and the German Monitoring Centres for Drugs and Drug Addiction organized on 22 September 2010 a meeting in Lisbon on practices and current issues in opioid substitution treatment in General Practitioners' settings in Europe.

The meeting aimed to provide a platform where General Practitioners from a number of European countries can share national experiences on topics of common interest related to the involvement of General Practitioners in the provision of opioid substitution treatment. The topics of discussion were developed together with GPs, researchers, the EMCDDA and REITOX National Focal Points.

The meeting was split into two thematic sessions. The first session discussed ‘Experiences and issues in the management of drug, health and social co-morbidities among clients in opioid substitution treatment with GPs’ with presentations by national representatives and researchers from Germany, Croatia and the United Kingdom. 

The second session discussed ‘Experiences and issues regarding access to opioid substitution treatment through GPs and risk of diversion and misuse of opioid substitution medications’ and which included presentations by national representatives and researchers from France, the Czech Republic, Norway and Austria.

The main outcomes of the meeting as well as the presentations are available below. For further information on the meeting, please contact Alessandro Pirona.

The e-mail address has been inserted in a way discouraging spam. Please replace [a] by @ before actually using any of the e-mail addresses.